# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001013762-24-000756
Filing Date
2024-07-24
Accepted
2024-07-24 16:49:32
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-07-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM ARS | ea0209927-01.pdf | ARS | 2266359
| Complete submission text file | 0001013762-24-000756.txt |  | 3123132

Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-22873 | Film No.: 241138755
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)